Document:

First Amended and Restated Participation Agreement

 Exhibit 10.1 
 EXECUTION VERSION 
 First Amended and Restated 
 PARTICIPATION AGREEMENT 
 Between 
 INTERNATIONAL BUSINESS MACHINES CORP. 
 And 
 ADVANCED MICRO DEVICES, INC. 
 Dated

 August 15, 2008 
  

 1 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 This Participation Agreement (“Participation Agreement”) is made effective as of the twenty-fifth
(25th) day of June, 2008 (hereinafter referred to as the “Effective Date”) by and between International Business Machines
Corporation (“IBM”), incorporated under the laws of the State of New York, U.S.A. and having an office for the transaction of business at 2070 Route 52, Hopewell Junction, NY 12533, U.S.A, and Advanced Micro Devices, Inc.
(“AMD” or “Company”), incorporated under the laws of the State of Delaware, U.S.A, and having an office for the transaction of business at One AMD Place, Sunnyvale, CA 94088-3453 for the Development Projects referenced on
Exhibit A attached hereto (collectively, the “Development Projects”). 
 WHEREAS, IBM and Company previously entered into the Third
Amendment and Restatement of the “S” Process Development Agreement as of December 28, 2002 (hereinafter “SPDA”) to develop certain SOI process technologies; 
 WHEREAS, IBM is pursuing or intends to pursue each of the Development Projects alone or in conjunction with one or more Participating Parties, as such Development Projects are more particularly described in the
Project Agreements; 
 WHEREAS, Company seeks to participate as a Participating Party in each of the Development Projects with IBM and the other
applicable Participating Parties; and 
 WHEREAS, IBM seeks to permit such participation in each of the Development Projects based upon the
terms and conditions set forth in (i) the applicable Project Agreement (including the Master Terms), which governs matters between and among all Parties, and (ii) this Participation Agreement, which governs certain supplemental matters
between IBM and Company. 
 NOW THEREFORE, in consideration of the premises and mutual covenants contained herein, as well as for other good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, IBM and Company agree as follows. 
 1. Additional Definitions.
Unless expressly defined and used with an initial capital letter in this Participation Agreement, the Project Agreement, or the Master Terms, words shall have their normally accepted meanings. Each of the following terms has the meaning
ascribed to it below: 
 “Baseline Fees” is defined in Section 5(a). 
 “BEOL” (Back End of Line) shall mean those aspects of Background Know-How and Specific Results that are directed to methods and processes of
interconnecting the source, gate, or drain electrodes of FET transistors formed on a wafer, including initial passivation of such FET transistors with a dielectric, up to and including polyimide passivation and final via formation but not including
Packaging Technology. For the avoidance of doubt, “BEOL” shall not include local interconnects made of tungsten. 
 “Company
Participation Period(s)” is defined in Section 3. 
  

 2 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 “Derivative Process(es)” shall have the meaning ascribed to it in Section 7(f). 
 “Development Projects”
means those particular Development Projects identified on Exhibit A. 
 “Foundry Company(ies)” means an entity having a majority of
its revenue arising from the sale of Integrated Circuits wherein all the following conditions are met: (i) the design, or masks and/or mask build data, for such Integrated Circuit product are provided to the Foundry Company from a party other
than the Foundry Company; (ii) such Foundry Company played no substantial role in any phase of the design of such product (except for providing standard design libraries, design enablement tools or other intellectual property to the party other
than the Foundry Company to specifically assist with the design of the product); and (iii) such Foundry Company is contractually bound to manufacture such product solely for, and to sell such product solely to, such party other than the Foundry
Company or its distributor or other recipient solely for the benefit of such party other than the Foundry Company. Foundry Company also includes any other entity that has as its primary business the manufacture of Industry Standard Integrated
Circuits, wherein at least fifty percent (50%) of the ownership interest in such entity is held by a Foundry Company (as defined in the first sentence of this paragraph), and wherein such Foundry Company and no other entity provides day-to-day
control and decision-making authority as to the manufacturing operations of such entity. 
 “Foundry Entity” means a Third Party
entity which derived more than [****] dollars of revenue from sale of foundry products (defined as for Foundry Products except with such entity named in place of Company) in fiscal year 2007. 
 “Foundry Product” means an Integrated Circuit wherein all the following conditions are met: (i) the design, or masks and/or mask build
data, for such Integrated Circuit product are provided to Company from a Third Party; (ii) Company played no substantial role in any phase of the design of such product (except for providing standard design libraries, design enablement tools or
other intellectual property to the Third Party to specifically assist with the design of the product); and (iii) Company is contractually bound to manufacture such product solely for, and to sell such product solely to, such Third Party or its
distributor or other recipient solely for the benefit of such Third Party. 
 “High Performance Information” means aspects of
Background Know-How or Specific Results of any one or more Development Projects, except for Industry Standard Information. 
 “Industry
Standard Development Projects” means the Development Projects pursuant to any of the following Project Agreements: 
 (1) [****]; or

 (2) [****]; or 
 (3) [****];
or 
  

 3 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 (4) [****]; 
 (5) [****]; or 
 (6) [****]. 
 “Industry Standard Information” means Background Know-How or Specific Results of any Industry Standard
Development Project and Background Know-How or Specific Results of any other Development Projects other than Protected High Performance Information selected by IBM and Company pursuant to Section 7(f). 
 “JMP” means a Third Party who is licensed by Company pursuant to Section 7(a) of this Participation Agreement to manufacture Integrated
Circuits in a joint manufacturing facility utilizing the Background Know-How and Specific Results of any Development Project (excluding High Sensitivity Pre-T0 Information). 
 “Key Information” means Industry Standard Information that enables a Third Party to engage in installation of the unit process modules, process
integration flow, or yield enhancement activities of the relevant technology excluding information that enables a licensee of such Key Information to 1) sign and confirm that a license exists, 2) present an implementation roadmap for the licensed
technology, and 3) build and equip a manufacturing facility, excluding specific recipe details. 
 “Master Terms” means the Master
IBM Joint Development Terms and Conditions that are incorporated by reference into the Project Agreements. 
 “Net Sales” means the
net revenue recorded by Company (including its Wholly Owned Subsidiaries) with respect to the first sale or other transfer of unbumped product wafers less (a) shipping, (b) insurance, and (c) sales, value added, use or excise taxes,
to the extent to which such items (a), (b) or (c) are actually paid or allowed, and less allowances to the extent they are actually allowed. If such wafers are sold or otherwise transferred in a higher level of assembly or with further
processing or in the course of a transaction that includes other products or services with no separate bona fide price to be charged for such wafers, the applicable Net Sales for the purpose of calculating Revenue Based Fees shall be the fair market
value of the unbumped wafers. 
 “Participation Effective Date” means, for each Development Project, the earlier date referenced
under Company Participation Period in Exhibit A for the respective Development Project. 
 “Participation Agreement” means this
“First Amended and Restated Participation Agreement between International Business Machines Corporation and Advanced Micro Devices, Inc.” 
 “Project Agreement” means the Project Agreement governing the respective Development Project, as referenced on Exhibit A. 
 “Protected High Performance Information” is defined in Section 7(f). 
  

 4 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 “Revenue Based Fees” is defined in Section 5(b). 
 “SOI Wafer” shall mean a single-crystal silicon wafer bearing a horizontally-disposed isolating silicon dioxide (SiO2)
layer, in turn bearing a single-crystal silicon layer or a polysilicon layer, which is separated from the underlying silicon by the silicon dioxide layer and in which one or more active or passive integrated circuit structures are formed.

 “SPDA” is defined in the recitals of this Participation Agreement. 
 2. Binding Contract; Relationship to the SPDA. 
 (a) By
executing this Participation Agreement and the respective “Participating Party Notification” attached as Exhibit C and upon Company board approval, such approval to be received no later than September 15, 2008 (absent such approval
this Agreement shall be null and void ab initio and any Confidential Information received hereunder shall be destroyed), (i) Company joins each of the respective Development Projects as a Participating Party, (ii) Company and the
other Participating Parties are each directly contracted to IBM and to each other based upon the terms and conditions of the respective Project Agreement (including the Master Terms and any language herein applicable to the respective Project
Agreements), without the need for any additional documentation or signatures by any Party, and (iii) Company is estopped from contesting its direct privity of contract with the other Participating Parties and with IBM on such referenced terms
and conditions. Exhibit D provides a list of the Participating Parties in each of the Development Projects as of the Participation Effective Date. IBM will record updates to this list on the respective Project Database. 
 (b) Company and IBM recognize that certain of their bilateral development effort pursuant to the SPDA must be replaced in order to facilitate IBM and Company’s
continued development with other Participating Parties pursuant to the applicable Development Projects. Accordingly, IBM and Company agree that, as of the Participation Effective Date, the development activities pursuant to the SPDA, or portions
thereof, listed in Exhibit E to this Participation Agreement permanently end and such development recommences pursuant to such Project Agreements and this Participation Agreement. The SPDA continues in full force and effect, however the parties
hereto contemplate terminating the SPDA, in part, in the future subject to negotiating which of the SPDA’s provisions will survive. Notwithstanding the foregoing, as of the date of the last signature hereto, for the Development Projects listed
in Exhibit A this Agreement shall supercede the provisions of Sections 5.1-5.3, 5.6, 5.7, 5.8, 5.10, 5.11 and 4.6 of the SPDA. 
 (c) The language in
Exhibits F and G attached hereto contain additional Company-specific terms and conditions agreed to by IBM and Company. Such terms and conditions are incorporated herein and form an integral part of the Agreement. 
  

 5 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 3.
Company Participation Periods; Term. Company shall participate and is only authorized to participate in the Development Project(s), commencing on the Participation Effective Date and continuing for the applicable periods for the Project
Agreements referenced in Exhibit A attached hereto (“Company Participation Period(s)”), regardless of whether the applicable Project Term extends beyond a Company Participation Period for such Development Project. The term of this
Participation Agreement shall commence on the Effective Date and, unless terminated prior to expiration as set forth elsewhere in the Agreement, shall remain in force until the earlier of (i) expiration or earlier termination of all Project
Agreements referenced on Exhibit A, or (ii) December 31, 2015. 
 4. Company Staffing. Company shall provide IBM with Representatives
to work on the Development Projects in accordance with the minimum staffing levels detailed on Exhibit B attached hereto. 
 5. Company Contributions
and Other Payments. In consideration for Company’s right to participate in the Development Projects commencing as of the Participation Effective Date, Company shall timely pay IBM quarterly development fees which are the greater of
Baseline Fees pursuant to subsection (a) below or Revenue Based Fees pursuant to subsection (b) below. Company’s contributions will be calculated during the second calendar quarter of each year and be in effect for the subsequent four
calendar quarters. Beginning in the fourth calendar quarter of 2008, all such payments shall be made within forty-five (45) days after receipt by Company of a quarterly invoice from IBM but no earlier than on the fifteenth day of the first
month of each calendar year quarter. For the third calendar quarter of 2008, such payments shall be made within forty-five (45) days after receipt by Company of an invoice from IBM but in no case later than September 30, 2008. 

 

 6 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

	(a)	Baseline Fees, in millions of dollars per calendar quarter, shall be determined according to the tables below. 

  

																													
	3Q08	 	4Q08	 	1Q09	 	2Q	 	3Q	 	4Q	 	1Q10	 	2Q	 	3Q	 	4Q	 	1Q11	 	2Q	 	3Q	  	4Q	  	1Q12
	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	  	[****]	  	[****]
															
	2Q12	 	3Q	 	4Q	 	1Q13	 	2Q	 	3Q	 	4Q	 	1Q14	 	2Q	 	3Q	 	4Q	 	1Q15	 	2Q	  	3Q	  	4Q
	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	 	[****]	  	[****]	  	[****]

 (b) Revenue Based Fees shall be calculated based on Company’s Net Sales during Company’s preceding
fiscal year of products or services manufactured using, embodying, derived from or otherwise based upon any Background Know-How or Specific Results of a Development Project as follows: 
 (i) [****] percent ([****]%) of Net Sales for products, consumed by Advanced Micro Devices, Inc., or sold or transferred to Advanced Micro Devices, Inc.
by any permitted assignee hereunder of Advanced Micro Devices, Inc., based upon substantially all of the High Performance Information derived from the relevant high performance Development Project, plus; 
 (ii) [****] percent ([****]%) of Net Sales (excluding for clarity Net Sales from (i) above) for products, consumed by Advanced Micro Devices, Inc.,
or sold or transferred to Advanced Micro Devices, Inc. by any permitted assignee hereunder of Advanced Micro Devices, Inc., based upon Industry Standard Information, plus; 
 (iii) [****] percent ([****]%) of Net Sales for products based upon Specific Results or Background Know-How of any Development Project and sold to, transferred to or consumed by any third party who is licensed by IBM
to manufacture products using Specific Results or Background Know-How of the same Development Project, plus; 
 (iv) [****] percent ([****]%)
of Net Sales for products based upon Specific Results or Background Know-How of any Development Project and sold to, transferred to or consumed by any third party who is licensed by IBM to Specific Results or Background Know-How of the same
Development Project wherein such license does not include the right to manufacture products using such Specific Results or Background Know-How, plus; 
 (v) [****] percent ([****]%) of Net Sales for products sold to, transferred to or consumed by any other third party. 
  

 7 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 The percentage values stated above in 5(b)(i) through (v) will prospectively change to [****], [****], [****], [****], and [****] percent, respectively, should Company merge with or acquire (including reverse merger or reverse
acquisition) [****] (“[****]”) while [****] is a Participating Party in a major node IBM Development Project or within nine (9) months after [****] ceases to be a Participating Party in a major node IBM Development Project.

 For avoidance of doubt each product consumed by, sold to or transferred to Advanced Micro Devices, Inc. or any third party shall fall under
only one revenue category under subsections 5.(b)(i) through (v) above for purposes of calculating Revenue Based Fees. 
 Company’s
quarterly Revenue Based Fees shall be one quarter of the amount indicated above. For avoidance of doubt, the establishment of a half-node process technology Development Project(s) and Company’s participation in such project(s) will not increase
Company’s fee schedule. 
 Company’s total yearly Revenue Based Fees in any given year shall not exceed two (2) times the
corresponding yearly amount of Company’s Baseline Fees indicated above. Should Company merge with or acquire (including reverse merger or reverse acquisition) [****] (“[****]”) then Company’s total yearly Revenue Based Fees in
that year and any subsequent year shall not exceed three (3) times the corresponding yearly amount of Company’s Baseline Fees indicated above. 
 To the extent it has the right to do so, which right IBM will make a good faith effort to obtain, IBM shall promptly notify Company after it enters into, or terminates or alters, any relevant licensing arrangement affecting the appropriate
categorization of transfers above which would allow Company to correctly calculate Revenue Based Fees under subsections (iii) and (iv) above. Company shall not be liable for any underpayments which result from IBM’s failure to provide
such notification. No later than March 31 of each calendar year, Company shall provide to IBM a written statement containing Company’s Net Sales during the preceding fiscal year in each of the above categories, the calculated percentages
according to the above and the total amount of Revenue Based Fees. Company shall maintain a complete, clear and accurate record of the quantity of products sold or otherwise transferred or consumed and any other relevant information to the extent it
is required to determine whether they are reporting the correct Revenue Based Fees hereunder. To ensure compliance with the terms and conditions of this Agreement, IBM shall have the right to audit all relevant accounting, technical and sales books
and records of Company. The audit will be conducted by a mutually acceptable audit firm, and shall be conducted following reasonable prior written notice (at least forty-five (45) days in advance) during regular business hours at an office
where such records are normally maintained and in such a manner as not to interfere with Company’s normal business activities and shall be restricted only to those records necessary to verify Company’s obligations hereunder. The audit
report provided to IBM may only include 

  

 8 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
the information necessary to determine whether or not any underpayment or overpayment exists, and if it exists, the amount of such underpayment or
overpayment. IBM shall instruct the auditor to include only business information in the audit report to IBM. IBM shall use the business information reported by the auditor only for the purpose of determining royalty payments and for no other
purpose. In no event shall audits be made hereunder more frequently than once in every twelve (12) months and the audit shall not cover any records from a period of time previously audited. If any audit should disclose any underpayment or
overpayment, the owing Party shall within forty-five (45) days pay the difference. The cost of such audit will be borne by IBM. Company shall be provided with a copy of the audit report within a reasonable period of time after its completion.
The independent audit firm shall not be hired on a contingent fee basis and Company shall have the right to require such audit firm to sign a confidentiality agreement sufficient to protect Company’s confidential information. 
 (c) Company shall be liable for interest on any overdue payment under this Agreement commencing on the date such payment becomes due at an annual rate equal to eighteen
percent (18%) per year. If such interest rate exceeds the maximum legal rate in the jurisdiction where a claim therefor is being asserted, the interest rate shall be reduced to such maximum legal rate. 
 (d) IBM shall apply the payments of this Section 5 towards Development Project costs and not for any license rights granted by any Party to any other Party for
Background Know-How. 
 (e) In consideration for the licenses granted to Company to Background Know-How of the 32nm Bulk Industry Standard Semiconductor
Process Technology and 32nm Bulk-Industry Standard Enablement Technology Development Projects, Company shall pay to IBM [****] dollars ($[****]) according to the following schedule: $[****] on or before September 30, 2008; $[****] on or before
December 30, 2008, $[****] on or before January 15, 2009; $[****] on or before April 15, 2009 and $[****] on or before July 15, 2009; which obligation shall be irrevocable and which payment when made shall be non-refundable. The
first two payments under this section will be due and payable on the respective dates specified with this Agreement serving as the invoice. All subsequent payments shall be made within forty-five (45) days after receipt by Company of a
quarterly invoice from IBM; however, in no case will Company be required to payment before the dates specified above. 
 (f) Each Party shall bear and pay
all taxes (including, without limitation, sales and value added taxes) imposed upon it by the national government or political subdivision thereof, of any country in which they are doing business as a result of the existence of this Agreement or the
exercise of its rights hereunder. Except as expressly provided in this Agreement, neither Party shall be entitled to any payment, cost reimbursement, or other compensation from the other for services, deliverables and rights granted to the other
Party hereunder. Each Party shall bear all its own expenses incurred in the performance of this Agreement. All payments due hereunder shall be paid in United States dollars. 
  

 9 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 6.
Limitation Amount. Notwithstanding the Limitation Amount provided in the Project Agreement, the Limitation Amount as between IBM and Company for all Development Projects in the aggregate is [****] dollars. 
 7. Confidentiality; Information Transfers; Licenses to Background Know-How.  
 (a) Joint Manufacturing Rights. IBM hereby grants to Company the right to disclose and sublicense Background Know-How and Specific Results of any Development Project (excluding High Sensitivity Pre-T0
Information) subject to the following requirements. Company may sublicense no more than two (2) JMPs for a maximum of a total of two (2) joint manufacturing facilities with a combined maximum capacity of producing [****] 300 mm wafers per
month for such technology consumed by, or supplied to the JMPs. Said combined maximum volume amount for a specific technology will apply until the confidentiality period for that specific technology expires. Company must own greater than fifty
percent (50%) interest (defined in the same manner as for Subsidiary) in the joint manufacturing facility and the JMP own the remaining interest except for any interest owned by a government entity or institutional investor (“Inactive
Owners”). The Inactive Owners shall not be in the business of manufacturing Integrated Circuits and will not be granted access to any Key Information. Company and the JMP will provide day-to-day control and decision making authority as to the
manufacturing operations of their joint manufacturing facility. The JMP will derive no more than fifty percent (50%) of its total revenue from foundry related business. The JMP will not be based in Asia (which for purposes of this
Section 7(a) Asia does not include Japan, Korea or Singapore). The JMP will not have the right to use the licensed technology to provide foundry services. The JMP will not have the right to use the licensed technology other than in the joint
manufacturing facility. The JMP will not be any party who contracts with IBM to conduct joint development of semiconductor process technology any sooner than 18 months after the later termination of either the IBM joint development or joint
manufacturing partner relationship between IBM and such aforementioned company. The joint manufacturing facility will not be located in Asia. Notwithstanding the foregoing, [****] may be a JMP. 
 If Company builds or has built a manufacturing facility for the purpose of exercising Company’s rights and performing Company’s obligations under the
immediately preceding paragraph of this Section 7(a) and Company and a first or second JMP cannot utilize all of the combined maximum capacity of [****] 300 mm wafers per month, then six (6) months prior to start of installation of any
process technology for volume production for any unutilized combined maximum capacity, and yearly thereafter for any uncontracted, unutilized combined maximum capacity, Company will so notify IBM in writing, and IBM will have the right of first
refusal of the unutilized combined maximum capacity at a price to IBM of the then current average market price for such wafers less twenty percent (20%), but in no event will such price to IBM be greater than that offered by Company to its most
favored customer under substantially similar terms and conditions. For the capacity that IBM refuses, Company may sell foundry wafers 

  

 10 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
including Foundry Products subject to this Section 7(a) to Third Parties (other than those that are not permitted to be a JMP) provided that:
(i) all such sales are made more than two (2) years after the applicable L2 for the technology in which such wafers are manufactured and (ii) all such sales shall be included in the calculation of Revenue Based Fees under
Section 5(b). The foregoing notification obligation will cease when the confidentiality obligation for a technology expires. 
 (b) Have-Made
Rights. Except as expressly provided herein, Company shall have no right to disclose or sublicense Background Know-How or Specific Results of any Development Project for the purpose of having products made by a Third Party in a manufacturing
process whose minimum critical dimension is less than or equal to that of the 32nm High Performance Semiconductor Process Technology Development Project or the 32nm Industry Standard Semiconductor Process Technology Development Project. 

(c) Third Party Joint Development. Except as specifically set forth in a Project Agreement or in this Participation Agreement, Company shall have no right to
disclose or sublicense Background Know-How or Specific Results of any Development Project to any Third Party for the purpose of engaging in joint development of semiconductor process or design enablement technology with such Third Party. 

(d) Foundry Entities. IBM shall not disclose to a Foundry Entity any Key Information prior to one (1) year after the applicable Qualification.
Furthermore, IBM shall not allow a Foundry Entity to become a Participating Party in any Development Project to which Company is a Participating Party or in which Development Project Company is actively in negotiation with IBM to become a
Participating Party until six (6) months after IBM has offered participation in such Development Project to Company or immediately upon Company declining such participation, whichever is earlier. 
 (e) Foundry Services. Notwithstanding anything to the contrary in this Agreement, Company may use High Performance Information to produce Foundry Products or
produce Foundry Products on SOI Wafers only for sale, lease or transfer to IBM, other Participating Parties in the Development Project from which such High Performance Information is derived, licensees of such High Performance Information from IBM
or sale, lease or transfer to Advanced Micro Devices, Inc. from any subsequent assignee. For avoidance of doubt, Industry Standard Information may be used to produce Foundry Products for any Third Party, subject to all the terms and conditions of
this Agreement including Section 5(b) of this Participation Agreement. 
 (f) Derivative Processes and Protected High Performance Information.

 The license granted to Company in Section 8.1 of the Master Terms shall include the right for Company to utilize one or more aspects of Industry
Standard Information for the development and qualification of its own, proprietary derivative process(es) (“Derivative Process(es)”) and for developing, engineering, manufacturing, using, marketing, selling, servicing and otherwise
disposing of Integrated Circuits utilizing such Derivative Process(es), other than Integrated Circuits created using High Performance Information, such Integrated Circuits being designed by any party. It is expressly confirmed that such license
shall include the right for Company to develop Derivative Process(es). 
  

 11 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 The IBM
Project Leader and the Company Project Leader shall mutually agree on a documented list of elements of the Specific Results and Background Know-How thereof that may not be utilized in a Derivative Process (“Protected High Performance
Information”). The following criteria will be seriously considered when defining elements included as Protected High Performance Information: 
  

	 	•	 	 such elements do not include Background Know-How or Specific Results of any Industry Standard Development Project to the extent, and only to the extent, included in
such Development Project, 

  

	 	•	 	 in the reasonable belief of the IBM and Company Representatives such elements are not being targeted for or included in the applicable technology node of other
Foundry Companies, 

  

	 	•	 	 such elements are not reported in the literature in sufficient detail that they can be implemented based upon reported results and methods, combined with
“residuals” (as defined in Section 9.1 of the Master Terms) and limited experimental development, and 

  

	 	•	 	 such elements do not include BEOL or Lithography steps. 

 The IBM and Company Management Committee Members shall attempt to agree upon a designation of Protected High Performance Information no later than ninety (90) days after the T0 exit checkpoint for the applicable Development Project.

 If significant elements of high performance Specific Results or Background Know-How become available at any time after the initial designation of
Protected High Performance Information and before the T1 exit (“T1” date) of the applicable high performance Development Project, the IBM Project Leader may provide additional such elements for designation as Protected High Performance
Information and shall consult with the Company Project Leader, who shall provide his input as to the applicability of such elements for designation as Protected High Performance Information. The IBM and Company Management Committee Members shall
mutually agree upon the designation of such elements within ninety (90) days. Such elements shall be treated as Protected High Performance Information until mutually agreed upon by IBM and Company. 
 Any elements of Specific Results or Background Know-How that are or that become Industry Standard Information for a given Development Project shall automatically be
included as Industry Standard Information in preceding (larger node) Development Projects and shall not be treated as Protected High Performance Information for such preceding Development Project(s). 
 In addition to the process described above in this Section 7(f) the documented list may be updated from time to time by written mutual agreement of the Management
Committee Members of IBM and Company. 
  

 12 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 If the Project Leaders fail to agree on the designation or removal of elements of high performance Specific Results
or Background Know-How as Protected High Performance Information, the decision will be escalated to the Management Committee Members of IBM and Company, and if necessary to the Designated Executives, for resolution. If upon such escalation the
Designated Executives are unable to agree on the designation or removal of such elements as Protected High Performance Information, IBM shall make the final determination. 
 (g) If Company exercises its right to assign this Participation Agreement as provided in Section 8, Company will have the additional right to disclose the following portions of Specific Results and/or Background
Know-How from high performance Development Projects to Advanced Micro Devices, Inc. and its Wholly Owned Subsidiaries (the “AMD Group”) for the purpose of providing the AMD Group with Foundry Product: 
 Descriptions of manufacturing process flow (excluding detailed process information that could enable a party to engage in installation of unit process
modules) as reasonably necessary for AMD Group to work with Company in the development of DFM techniques and structures, and to assess layout considerations, electrical performance, reliability, yield, cost, risk and/or schedule; and 
 Detailed information relating to processes used for FET, only to the extent necessary to support device level simulation for the purpose of modeling the
electrical behavior of such devices. 
 (h) If Company exercises its right to assign this Participation Agreement as provided in Section 8, Company and
Advanced Micro Devices, Inc., and its Wholly Owned Subsidiaries will have the additional right to disclose the following portions of Specific Results and/or Background Know-How to Advanced Micro Devices, Inc.’s customers for the purpose of
exercising Company’s rights under this Agreement: 
  

	 	•	 	 process roadmap and development schedule for the Development Project(s); 

  

	 	•	 	 simplified process flow (indicative of rough number of process and mask steps); and 

  

	 	•	 	 reliability data and specifications. 

 (i)
Disclosures made pursuant to Sections 7(g) and 7(h), above, shall be subject to all the confidentiality terms and conditions of Section 4(c) of the relevant Project Agreement(s) and, in addition, in the case of the Joint Development Project
Agreement for Pre-T0 Semiconductor Technology Research, Section 4(d). 
 8. Assignment. No Party may assign any of its rights or delegate
any of its obligations under this Agreement without prior written permission from the other Party. Any attempted such assignment or delegation without such permission shall be null and void. If IBM reorganizes its business so as to set up a Wholly
Owned Subsidiary that shall include the entire business and assets responsible for such IBM’s performance of its obligations under this Agreement, then Company agrees that the permission to assign and 

  

 13 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
delegate to such Wholly Owned Subsidiary shall not be unreasonably withheld. Furthermore, IBM may assign its right to receive payments under this Agreement.
Notwithstanding the foregoing, if Company reorganizes its business so as to set up a Wholly Owned Subsidiary or new legal entity that shall include substantially its entire business and assets related to manufacturing of semiconductor wafers, or if
Company’s entire business and assets related to manufacturing of semiconductor wafers is acquired by a Third Party, then Company may assign all of its rights and delegate all of its obligations under this Agreement without prior permission of
IBM to such Wholly Owned Subsidiary, new legal entity or acquiring Third Party. For avoidance of doubt, such an assignment by Company will not be deemed a Change of Control under this Participation Agreement. 
 9. Termination. In addition to Section 12 of the Master Terms, the following termination terms and conditions apply as between IBM and Company:

 (a) The following Sections of this Participation Agreement survive and continue to bind IBM and Company and their legal representatives, successors and
assigns after the expiration of this Participation Agreement: 1, 2 (only to the extent necessary for the validity of the surviving terms), 6, 7, 9, 10, 12, 14; provided, however, a Company’s surviving license and disclosure rights pursuant to
Section 7 only apply to the information as it existed at the end of its participation in the applicable Development Project. In addition, certain provisions of the Master Terms and Project Agreement survive, as detailed in each agreement,
respectively. For clarity, the expiration of this Participation Agreement does not, in and of itself, affect the SPDA. 
 (b) Either Party shall have the
right to immediately terminate this Agreement as to a breaching Party (as defined herein in 1), 2), 3) or 4) below) by giving written notice of termination to the other Party if the other Party (the “breaching Party”) 1) becomes insolvent
or permanently ceases doing business; 2) is adjudged bankrupt or insolvent or files a petition for bankruptcy; 3) goes into liquidation; or 4) undergoes a Change of Control. 
 A “Change of Control” shall be deemed to have occurred if (a) there shall be consummated (i) any consolidation or merger of a Party in which such Party is not the continuing or surviving entity, or
pursuant to which shares of such Party’s equity securities would be converted into cash, securities or other property, other than a consolidation or merger of such Party in which the holders of such Party’s equity securities immediately
prior to the merger have substantially the same proportionate ownership of equity securities of the surviving entity immediately after the merger, or (ii) any sale, lease, exchange or other transfer (in one transaction or a series of related
transactions) of all or substantially all the assets of such Party; (b) the equity holders of a Party shall approve any plan or proposal for the liquidation or dissolution of such Party, or (c) any person (as such term is used in section
13(d) and 14(d) (2) of the Securities Exchange Act of 1934 (the Exchange Act”) other than a Party or any employee benefit plans sponsored by such Party, shall become the beneficial owner (within the meaning of 

  

 14 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
Rule 13d-3 under the Exchange Act) of securities of the company representing: (i) more than one third of voting securities having the voting power of
such Party’s then outstanding securities ordinarily (and apart from rights accruing in special circumstances) having the right to vote in the election of directors, as a result of a tender or exchange offer, open market purchases, privately
negotiated purchases, or otherwise, only if such person and its Subsidiaries exceeded ten billion US dollars in revenue from the sale of microprocessors in calendar year 2001; or (ii) fifty percent (50%) or more of voting securities having
the voting power of such Party’s then outstanding securities ordinarily (and apart from rights accruing in special circumstances) having the right to vote in the election of directors, as a result of a tender or exchange offer, open market
purchases, privately negotiated purchases, or otherwise. Notwithstanding the foregoing, a change of ownership or control effected solely through an investment of Venture Capitalist(s) in a Party shall not be considered a “Change of
Control.” For the avoidance of doubt, a change of ownership or control of Company effected through an initial public offering of Company (unless effected solely through such a Venture Capitalist investment) shall be considered a “Change of
Control” only if it meets the criteria set forth above in clauses (a), (b) or (c) of this paragraph. “Venture Capitalist” means an investor or prospective investor of either Party whose business is primarily investment or
banking and specifically not the development, sale or manufacture of Integrated Circuits, computer or network systems or infrastructure for the foregoing. For avoidance of doubt, such a transaction wherein the beneficial owner of voting securities
is Advanced Micro Devices, Inc. or a Venture Capitalist shall not be considered a Change of Control. 
 (c) If either Party to this Agreement fails to
perform or violates any material obligation of this Agreement, then, upon thirty (30) days written notice to the breaching Party specifying such failure or violation (the “Default Notice”), the non-breaching Party may terminate this
Agreement as to the breaching Party, without liability, unless: 
 The failure or violation specified in the Default Notice has been cured
within a thirty (30) day period; or 
 The failure or violation reasonably requires more than thirty (30) days to correct
(specifically excluding any failure to pay money), and the breaching Party has begun substantial corrective action to remedy the failure or violation within such thirty (30) day period and diligently pursues such action, in which event,
termination shall not be effective unless ninety (90) days has expired from the date of the Default Notice without such corrective action being completed and the failure or violation remedied. 
 (d) Company shall have the right to immediately terminate (without liability to any Party) this Agreement by giving written notice of termination to IBM, if IBM sells,
leases, exchanges or otherwise transfers (in one transaction or a series of related transactions) the assets of its microelectronics business unit required to perform its obligations under this Agreement. 
  

 15 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 (e) In
the event that Company does not reorganize its business so as to set up a new legal entity that shall include substantially its entire business and assets related to manufacturing of semiconductor wafers, or that substantially all of Company’s
business and assets related to manufacturing of semiconductor wafers is not acquired by a Third Party (each referred to as a “Failed Funding”) prior to March 31, 2009, then Company shall provide IBM written notice of the Failed
Funding. In such event, Company shall have thirty (30) days to elect, by written notice to IBM, one of the following alternatives: (i) to terminate this amendment prospectively without cause and for convenience; or (ii) to extend the
time period for the effectiveness of this amendment for up to an additional nine (9) months in order to seek alternative funding for the new entity. Upon expiration of the additional funding term, set forth in subsection (ii) above, if
applicable, and Company’s written notification to IBM that the new entity has not then received adequate funding, this amendment shall automatically expire. All payments due and owing prior to termination or expiration of this amendment shall
remain due and owing and shall be timely paid. 
 10. Patent Licenses/No Patent Licenses. As contemplated in Section 8 of the Master
Terms, Exhibit A sets forth whether Company is a Patent Participating Party for each of the respective Development Project(s).  
 11. Company
Information; Participating Parties. In connection with Company’s execution of this Participation Agreement, IBM shall provide a copy of each such Participating Party Notification to the other respective Participation Parties in order
to, among other things, demonstrate Company as a Participating Party in each such Development Project. Notwithstanding anything in the respective Agreement to the contrary, Company expressly permits IBM to share the following information with Third
Parties who IBM believes may wish to participate in the subject Development Project(s): (i) the identity of the Company and (ii) whether Company is a Patent Participating Party for the applicable Development Project(s). IBM will promptly
deliver to Company copies of all other Participating Parties’ existing Participating Party Notification documents and subsequently executed Participating Party Notification documents for all Development Projects set forth on Exhibit A.

 12. General. 
 (a) This Participation Agreement
supplements the respective Project Agreement (including the Master Terms) and provides supplemental information as between IBM and Company that was intentionally omitted from the Project Agreement. Therefore, this Participation Agreement is not a
stand-alone agreement, but as between IBM and Company, merges with and becomes part of the terms and conditions of the respective Project Agreement. There are no intended third party beneficiaries to this Participation Agreement, including the other
Participating Parties; provided, however, Company is executing and providing a Participating Party Notification for each Development Project, and such document is for the express benefit of all Participating Parties. Promptly after the Participation
Effective Date, Company agrees to complete, execute and deliver to IBM one Participating Party Notification in the form attached as Exhibit C hereto for each Development Project. 
  

 16 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 (b) This
Participation Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but each of which together shall constitute one and the same agreement. Confirmed facsimile signatures shall have the same effect as
original signatures for the purpose of executing or amending the Participation Agreement. Once signed by IBM and Company, any reproduction of this Participation Agreement by reliable means (e.g. a facsimile, electronic scanning, or photocopy) shall
be considered an original. 
 13. Access to the CSR. The “CSR Access Terms” identified in Exhibit F to the Joint Development
Project Agreement for Pre-T0 Semiconductor Technology Research do not apply to Company so long as the Participation Agreement for IBM CSR Development Associate for the Center for Semiconductor Research at Albany Nanotech by and between IBM, Company
and the Research Foundation of the State University of New York remains in effect. 
 14. Separate Development Scope. For clarity, in addition
to IBM and Company’s joint development with one or more other parties pursuant to the Development Projects, IBM and Company shall continue to jointly pursue any development activities under the SPDA, or portions thereof, not identified in
Exhibit E to this Participation Agreement exclusively pursuant to the terms and conditions of the SPDA. 
 15. Extension of Project Agreements.
If the Project Term of the relevant Project Agreement is extended in accordance with Section 6 of such Project Agreement, then Company is, without additional consideration, entitled to participate in such extended Project Term until
December 31, 2015. 
 16. Additional Activities. If at any time during the term of this Agreement, IBM initiates one or more development
projects covering development of the next major industry standard or high performance technology node after 22nm, IBM will notify Company, and then Company agrees to participate in at least one such development project under the terms and conditions
of this Agreement and such participation will be set forth in a signed, written amendment hereto. If IBM has not established any such development project by [****], then this Agreement and Company’s participation in all Development Projects may
be terminated by either party hereto, without liability to any Party, as of [****], and Company will have no further payment obligations under Section 5 herein provided, however, that if such a development project is established after [****],
but prior to either party hereto’s exercise of its preceding right to terminate, the preceding right to terminate shall lapse. If IBM establishes a Development Project covering the next major technology node after 22nm in only high performance
technology, or if IBM establishes Development Projects for the next major technology node after 22nm in both industry standard and high performance technology and Company declines to participate in such high performance Development Project, then the
parties hereto will renegotiate reduced Company’s quarterly development fees (whether Baseline Fees or Revenue Based Fees) based on the scope of the Development Project in which Company agrees to participate, which will be set forth in a signed
written amendment hereto. For the avoidance of doubt, a “next major technology node” shall not include a half node. 
  

 17 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 IN
WITNESS WHEREOF, IBM and Company have caused this Participation Agreement to be executed by their duly authorized representatives as of the Participation Effective Date. 
  

									
	Advanced Micro Devices, Inc.	 		 	International Business Machines Corporation
					
	By:	 	/s/ D.A. Grose	 		 	By:	 	/s/ Bernard S. Meyerson
	Name:	 	D.A. Grose	 		 	Name:	 	Bernard S. Meyerson
	Title:	 	SVP Manufacturing Technology	 		 	Title:	 	VP & CTO
	Date:	 	August 15, 2008	 		 	Date:	 	August 15, 2008

  

 18 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT A – DEVELOPMENT PROJECTS 
 [****] 
  

 19 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT B – COMPANY STAFFING 
 [****] 
  

 20 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT C - PARTICIPATING PARTY NOTIFICATION. 
 Re: Participating Party Notification - Joint Development Project Development Agreement
for [                    ] (“Development Project”) dated as of
[                    ]. 
 To the
Participating Parties (current and future) in the Development Project: 
 [                                    ]
(“Company”) represents and warrants to IBM and the Participating Parties (for clarity, current and future) in the above-referenced Development Project that:
(i) [                                       
 ] has joined the above-referenced Development Project as a Participating Party as of the date listed below by signing a Participation Agreement with IBM, and (ii) Company and the other Participating Parties are each directly contracted
to IBM and to each other based upon the terms and conditions of the Project Agreement (including the Master Terms), without the need for any additional documentation or signatures by any Party, and (iii) Company is estopped from contesting its
direct privity of contract between itself and the other Participating Parties, and between itself and IBM on such terms and conditions. All terms not defined herein are defined in the Project Agreement. 
 Below is specific information applicable to the Company for the above-referenced Development Project: 
  

	 	1.	Company Name and Address: [                        ].

  

	 	2.	Company [is] [is not] a “Patent-Participating Party” for the above-referenced Development Project (See Section 8.6 of the Master Terms). 

  

	 	3.	“Notice Address” for the Company (See Section 13 of the Master Terms):
[                        ] 

  

	 	4.	Company “Designated Executive” and contact information (See Section 18 of the Master Terms):
[                        ] 

  

	 	5.	Company “Management Committee Member” and contact information (See Section 13 of the Master Terms):
[                        ] 

  

	 	6.	Company “Project Leader” and contact information (See Section 13 of the Master Terms):
[                        ] 

  

	 	7.	Company “Technical Coordinator” and contact information (See Section 13 of the Master Terms):
[                        ] 

  

 21 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

	 	8.	Company is currently scheduled to participate in the Development Project from              until
            , but the actual end date is subject to change without advance notice to the other Participating Parties. 

 Except for item 2 above, Company may update the representatives, contact, and notice information provided above. If Company elects to do so, it shall provide the revised
information to the IBM Designated Executive for inclusion on the Project Database. No update is effective until reflected on the Project Database. 
 This
document is non-confidential, and Company requests that IBM provide the above information to all Participating Parties and update the Project Database to reflect the above information. 
  

			
	[COMPANY NAME]
		
	By:	 	 
	Name:	 	 
	Title:	 	 
	Date:	 	 

  

 22 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT D – PARTICIPATING PARTIES (as of the August 8, 2008) 
 [****] 
  

 23 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT E – APPLICABLE SPDA PROCESS DEVELOPMENT PROJECTS 
 CMOS 12S (for clarity, excluding CMOS 12SeD) 
 CMOS 12S2 
 CMOS 13S (for clarity, excluding CMOS 13SeD) 
 CMOS 13S2 
 CMOS 14S 
 Pre-T0 Activities, excluding bump technology 
  

 24 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 EXHIBIT F – COMPANY ADDITIONAL PROJECT REQUIREMENTS 
 1. Chemical & Environmental Information 
 To the extent one Party (the “Disclosing Party”) possesses such information and has the right to disclose it to the other Party (the “Receiving
Party”), as set forth below, the Disclosing Party agrees to provide the Receiving Party with the following Chemical and Environmental Information described in (A) and (B) below (“C&E Information”) under this Agreement:

  

	(A)	C&E Information supplied to the Disclosing Party by third parties: 

 For each material used in Development Projects in which Receiving Party is a Participating Party, Disclosing Party will grant receiving party access to any related MSDS as well as any chemical constituent information
not listed in the MSDS unless the Providing Party is prohibited from providing such chemical constituent information with the Receiving Party. 
 To the extent that this information is provided by IBM, this C&E Information shall be provided by IBM EFK site chemical and environmental professionals. 
  

	(B)	C&E Information created or gathered by IBM as Disclosing Party. 

 (i) Until the earlier of: (a) Company ceases to be a Participating Party under a Development Project, or (b) IBM determines as part of a facility or corporate wide policy that its best interest is served by
terminating its alliance development companies’ access to this information, IBM will continue to permit Company to have access to CI ENV 116 (see [****]. 
 (ii) Until the earlier of: (a) Company ceases to be a Participating Party under a Development Project, or (b) IBM determines as part of a facility or corporate wide policy that its best interest is served by
terminating its alliance development companies’ access to this information, IBM will provide Company Chemical Authorization Requests and Notification of Approvals relating to the active Development Projects. Information is to be provided by IBM
EFK site chemical and environmental professionals. 
 (iii) With respect to the semiconductor manufacturing equipment jointly evaluated under
the Semiconductor Manufacturing Equipment Evaluation Agreement, dated as of April 21, 2004 between IBM and Company or as reasonably requested by Company, IBM will supply the following information (“Emissions Information”) with respect
to the emissions from any such tool (the “Emissions”): (a) the current drain type to which such Emissions is connected, (b) the current exhaust system type 

  

 25 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
to which such Emissions is connected, (c) a recent calculated average emission rate (mass per day) with respect to the emission stream flowing out of a
tool, and (d) a generic description of the current type of waste abatement or treatment that IBM applies to such emission stream (for example, combustion-type scrubbers). For the avoidance of doubt, IBM can not and will not parse the Emissions
Information to specifically link any portion of the Emissions to any particular technology node that is utilized with respect to such tool. Information is to be provided by IBM EFK site chemical and environmental professionals. 
 IBM Toxicology will share with Company new hazards (not identified in current MSDSs) for any chemicals found in the technologies covered within this
Agreement, for the term of each Project Agreement, that may be assessed in future upstream chemical reviews, subject to the following: 
  

	 	•	 	 IBM is not obligated to perform additional toxicology searches nor provide toxicology services to Company. 

  

	 	•	 	 Data will be provided “AS IS” with no warranty being made as to the accuracy or suitability of the data for a particular purpose.

 (C) With respect to all C&E Information, subject to the terms above, Disclosing Party will make good faith efforts to provide such
C&E Information unless Disclosing Party is restricted from providing such C&E Information by contractual obligations that Disclosing Party has established with one or more third parties. 
 (D) For confidentiality obligations that Disclosing Party enters into with third parties in the future and that relate to an active Development Project, Disclosing Party
will request that such third party give Disclosing Party the right to make such disclosures to the Receiving Party. In addition, as and if reasonably requested, Disclosing Party will provide Receiving Party with a list of suppliers with whom
Disclosing Party has a confidential disclosure agreement in place, which confidential disclosure agreement relates to a Development Project and restricts Disclosing Party’s ability to disclose C&E Information to Receiving Party. 

The obligations under Section 1 of this Exhibit F will terminate immediately upon the termination of the Participation Agreement. 
  

 26 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 2.
Additional Pre-T0 Joint Development Project Requirements 
 The following changes modify the terms and conditions of the Joint Development Project
Agreement for Pre-T0 Semiconductor Technology Research as indicated. In case of conflict, the requirements below will govern. 
 (a) For clarity, the
following Pre-T0 In-Scope Technical Subjects are not included in Exhibit E to this Participation Agreement: 
  

	 	•	 	 Bump technology 

  

	 	•	 	 Non-solder interconnect technology 

  

	 	•	 	 [****] 

 Including applicable tool
development, mechanical models, constituent equations, reliability (e.g., fatigue model) and electromigration results) 
 (b) For clarity and as provided for
in Exhibit D of the Project Agreement for Pre-T0 Semiconductor Technology Research, it is the responsibility of the Steering Committee to approve changes in Pre-T0 In-Scope Technical Subjects and projects as set forth in Exhibit A to the Project
Agreement for Pre-T0 Semiconductor Technology Research, with final approval to be provided from the Management Committee. 
 (c) For clarity, IBM and Company
hereby acknowledge that all Participating Parties to the Joint Development Project Agreement for Pre-T0 Semiconductor Technology Research, shall have access to all Specific Results and Background Know-How of such Development Project and that
documentation procedures will be established by mutual agreement of the respective Project Leaders during the course of the Development Project. 
  

 27 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXHIBIT G – ADDITIONAL COMPANY TERMS AND CONDITIONS 
 1. Intentionally Omitted. 
 2. In addition to the primary Development
Facilities specified in a Project Agreement pursuant to Section 2.2 of the Master Terms and Conditions, Company and IBM Project Leaders will mutually agree to the use of any additional Development Facilities in which Company’s
Representatives will work and will seek approval from the Management Committee in the case of a conflict. 
 3. Notwithstanding language to the contrary in
section 4.1.2 of the Master Terms and Conditions, the following shall apply: 
 If the Designated Executives are unable to resolve a
party’s hereto concern raised under Section 4.1.2, the Company and IBM will negotiate a mutually agreeable reasonable wind down plan (which may include negotiation of fees) to terminate the development relationship set forth in this
Agreement for any or all Development Project(s). 
 If the conditions for wind-down set forth in Section 4.1.2 of the Master Terms are
met for any process technology Development Project, then such wind down shall include the corresponding design enablement Development Project for the same technology node. 
 4. Company shall also have the right to disclose the following portions of the Specific Results and Pre-T0 Information (except for High Sensitivity Pre-T0 Information) to Third Parties, but solely for the purpose of
enabling such Third Party to assist Company in exercising the rights granted to it hereunder: 
 4.1. wafers and/or information to have
equipment maintained; or 
 4.2 spice models, design-related data (netlists, GDS), device models, verification decks; or 
 4.3 for clarity, Company’s disclosure rights under Section 4(c)2 of a Project Agreement shall include the right to disclose reliability data and
specifications. 
 5. Company’s rights under the respective Development Agreement to disclose wafers and process information to tool vendors as required
to have equipment maintained shall extend to all companies that provide such equipment maintenance to Company. 
 6. Notwithstanding language to the contrary
in Section 6.1 of the Master Terms, failure to achieve Strategic Technology Objectives or the Development Schedule shall constitute a basis to extend the Project Term, but only as provided for in Section 15 of this Participation Agreement.

  

 28 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 7. Intentionally Omitted. 
 8. As between IBM and Company, the confidentiality provisions of Section 7.3 of the Master Terms shall not apply to Specific Results and Background Know-How and other information of any Party in the case that such information is not
labeled in accordance with Section 7.2 of the Master Terms. 
 9. To the extent that either party hereto enters into a development agreement with its
equipment, design, and materials suppliers and elects to disclose the results of any such development to the other party hereto as Background Know-How under a Development Project or Pre-T0 Activity, and to the extent the disclosing party hereto has
the right to do so, the disclosing party hereto agrees to notify the other party hereto of such development agreement. Furthermore, the disclosing party hereto will consent to include a reasonable number of Representatives of the other party hereto
in technical discussions with each such supplier. The parties hereto will use reasonable efforts to accommodate such technical discussions at either party’s hereto facilities or via teleconference. Any additional information generated at such
meetings shall be the Background Know-How of the party hereto who has entered into such development agreement. 
 10. Bump Technology. 
 10.1 The Parties agree that all terms and conditions of the “C-4 Agreements” shall continue in full force and effect, and shall not be
superseded by this Agreement. For purposes of this Agreement, the “C-4 Agreements” shall mean collectively (1) the C-4 Plating Technology Transfer and Licensing Agreement between Company and IBM having a last signature date of
April 29, 1999; (2) the C-4 Tighter Pitch Workshop Agreement between Company and IBM having a last signature date of March 23, 2001; (3) the C-4 Technical Assistance and Short Loop Support Agreement between Company and IBM having
a last signature date of July 16, 2001; and (4) the Letter Agreement having a signature date of September 13, 2004. 
 10.2 If
at any time during the term of this Agreement, IBM initiates one or more development projects covering development of bump technology, IBM will notify Company, and if Company agrees to participate in at least one such development project under the
terms and conditions of this Agreement and such participation will be set forth in a signed, written amendment hereto. IBM agrees that Company will not be required to pay any additional fees to IBM for participation in such development project or
access to said bump technology. If a separate bump technology development agreement is entered between IBM and any Third Party(ies), IBM will use reasonable efforts to include Company in such development efforts, subject to the negotiation of
mutually agreeable terms and conditions between Company and the participants in such development efforts. 
  

 29 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 a. If Bump Technology is established as a Development Project under this Section 10.2:
(i) the Parties agree that Company may exercise at least the same rights to use and implement and have the same obligations with regard to said bump technology as Company currently exercises and has under the C-4 Agreements and (ii) if the
Parties, thereafter, mutually agree to expand the scope of a bump technology Development Project, such expansion will be governed by the terms and conditions of Section 14 of the Master Terms. 
 10.3 If bump technology is established as a Development Project, the Parties will provide, to the extent a Party has the right to do so without the
payment of additional compensation to any Third Party, to the bump technology Development Project any relevant information as Background Know-How. Additionally, to the extent that IBM does enter a separate bump technology development agreement with
a Third Party and IBM has the right to do so without the payment of additional compensation to any Third Party, IBM will grant a sublicense to Company to the technology developed thereunder without requiring any additional fees, which sublicense
shall be consistent with the licenses granted to Company under this Agreement and the C-4 Agreements. 
 11. For the avoidance of doubt, as set forth in
Section 10.1 of this Exhibit G, Company shall be permitted to perform bumping for up to [****] 200mm semiconductor wafers per calendar quarter and up to [****] 300mm semiconductor wafers per calendar quarter for third parties. For each
200mm wafer bumped for third parties in excess of [****] per calendar quarter, Company shall pay IBM a royalty of [****] percent ([****]%) of the bumping price charged by Company to the third parties. For each 300mm wafer bumped for third
parties in excess of [****] per calendar quarter, Company shall pay IBM a royalty of [****] percent ([****]%) of the bumping price charged by Company to the third parties. Company’s royalty obligation shall continue until December 31,
2011, after which time, Company may bump an unlimited number of wafers for third parties with no further royalty or reporting obligations, including no additional fees for Company or the third parties who have products bumped by Company. The audit
provisions of the last paragraph of Section 5(b) hereto shall apply to royalty obligations in this Section 11. 
 12. Development Projects shall be
conducted primarily at the IBM Development Facilities and the parties hereto agree that the process technology development projects performed under this Agreement (except for under the Pre-T0 Development Project) will be conducted primarily in
IBM’s 300mm East Fishkill Facility, unless otherwise agreed to by the Parties. 
 13. Should IBM desire, at its own discretion, that the process
technology development projects performed under this Agreement (except for under the Pre-T0 Development 

  

 30 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 
Project) be primarily conducted at facilities other than IBM’s 300mm East Fishkill facility, it shall provide notice of such desire to Company no later
than one (1) year prior to the intended change. The parties hereto will meet to discuss and attempt to agree on such a move. If the parties hereto are unable to reach agreement, the Designated Executives of IBM and Company shall negotiate a
mutually agreeable reasonable wind down plan to terminate (for convenience and without liability to either party hereto) the development relationship set forth in this Agreement. 
 14. For clarity and pursuant to Section 4(a) of the Pre-T0 Project Agreement, restrictions on High Sensitivity Pre-T0 Information shall not apply to Background Know-How or Specific Results of any other
Development Project in which Company is a Participating Party. 
 15. For the avoidance of doubt, if Company exercises its right to assign this Participation
Agreement as provided in Section 8, Advanced Micro Devices, Inc. will continue to have the right to disclose to companies providing design services to Advanced Micro Devices, Inc., library/IP creators, Electronic Design Automation
(“EDA”) vendors, consultants (such consultants including design service providers, integrated circuit designers, and external subcontractors) (collectively, “Consultants/Designers”) as may be reasonably necessary to enable the
design of Advanced Micro Devices, Inc. Integrated Circuits or Semiconductor Products. By way of example and not limitation, examples of the general types of information that are “reasonably necessary” for disclosure are as follows:

  

	 	A.	Design rules for the Development Project; 

  

	 	B.	Simplified process flow information (indicative of rough number of process and mask steps and excluding detailed process flow information and detailed process specifications);

  

	 	C.	Design manual; 

  

	 	D.	Device models; 

  

	 	E.	Checking decks; 

  

	 	F.	Electrical characterization / model information; and 

  

	 	G.	Model to hardware comparisons; 

  

	 	H.	Reliability data and specifications. 

 Disclosures pursuant to this
Section will not be made without a written agreement between Advanced Micro Devices, Inc. and the recipient Third Party. Such written agreements shall be subject to the following: 
  

	 	(a)	such agreements must obligate the recipient to utilize the disclosed information solely for the benefit of the discloser and for no other purpose; and 

  

	 	(b)	such disclosures shall be subject to confidentiality terms and conditions that are the same or substantially similar to those set forth in this Agreement, and at a minimum must have
a confidentiality term that is no shorter than five (5) years. 

  

 31 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
  

 16. Company agrees to provide [****] Representatives to the Development Projects in addition to the Representatives
assigned to work on the Development Projects as of June 30, 2008. Company will use commercially reasonable efforts to assign such additional Representatives to work in the Development Facilities according to the following schedule: [****]
additional Representatives as of October 31, 2008; [****] additional Representatives as of February 28, 2009; and five (5) additional Representatives as of June 30, 2009. However, if Company fails to provide such [****]
additional Representatives by June 30, 2009, or if Company’s number of Representatives subsequently falls below such staffing level, then Company’s quarterly Baseline Fees will increase by [****] dollars ($[****]) per Representative
for each month where such shortfall exists. 
 17. In addition to the documents (currently in Exhibit C) of the respective Process Technology Project
Agreements, the following will also be provided: Design Services Code (cheese/fill) and techfile documentation. 
  

 32 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions.Intellectual Property Cross License Agreement

 Exhibit 10.2 
 EXECUTION VERSION  
 AMD AND BROADCOM CONFIDENTIAL 
 INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT 
 This INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this “Agreement”) effective as of the Effective Date, is by and
between ADVANCED MICRO DEVICES, INC., a corporation organized under the laws of Delaware and having its corporate head office located at One AMD Place, Sunnyvale,
California 94088 (“AMD”) and BROADCOM CORPORATION, a corporation organized under the laws of California and having its principal place of business at 5300 California Ave.,
Irvine, California 92617 (“Broadcom”). 
 WHEREAS, Broadcom, AMD and Broadcom International Limited, a Cayman
Islands entity, have entered into that certain Asset Purchase Agreement dated August 25, 2008 (“APA”), pursuant to which Broadcom and Broadcom International Limited purchased and assumed, and AMD sold, transferred and
assigned to Broadcom and Broadcom International Limited, certain assets and liabilities of the Business; 
 WHEREAS, AMD desires to license
to Broadcom certain intellectual property rights and technology retained by AMD and currently used by the Business to enable Broadcom to conduct the Business and exploit the Purchased Assets after the Effective Date on the terms set forth herein;

 WHEREAS, Broadcom desires to license such intellectual property rights and technology from AMD to conduct the Business and exploit the
Purchased Assets on the terms set forth herein; 
 WHEREAS, Broadcom desires to license back to AMD the intellectual property rights and
technology acquired by Broadcom under the APA to enable AMD to continue, subject to AMD’s non-competition obligations under the APA, to conduct certain businesses retained by AMD after the Effective Date on the terms set forth herein; and

 WHEREAS, AMD desires to license such intellectual property rights and technology from Broadcom to conduct certain businesses on the terms
set forth herein; 
 NOW, THEREFORE, in consideration of the mutual promises of the parties, and of good and valuable consideration, it is
agreed by and between the parties as follows: 
  

	1.	DEFINITIONS 

 For the purpose of this Agreement the following
capitalized terms are defined in this Section 1 and shall have the meaning specified herein. Other terms that are capitalized but not specifically defined in this Section 1 or in the body of the Agreement shall have the meaning set forth
in the APA. 
  

 1 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 1.1 “AMD Exclusive Field” means the design, development, distribution,
marketing, manufacture, use, import, license and/or sale of any IP core, processor, integrated circuit or chipset, and Software operating thereon or in connection therewith, to the extent that any such IP core, processor, integrated circuit, chipset
or Software (i) operates as [****] for use in [****]); or (ii) (A) is able to execute the object code of any AMD Processor, (B) substantially utilizes the instruction set of any AMD Processor, or (C) has a programmer’s
model that is substantially compatible with the programmer’s model of any AMD Processor. Notwithstanding the foregoing, the “AMD Exclusive Field” does not include the design, development, distribution, marketing, manufacture, use,
import, license and/or sale of any of the following: (1) Current Business Products, Past Products or Roadmap Products, (2) the other products described in the first sentence of the “Broadcom Exclusive Field” definition,
(3) products [****], or (4) products [****]. 
 1.2 “AMD Technology” has the meaning ascribed to it in the
IP Core License Agreement. 
 1.3 “Broadcom Exclusive Field” means the design, development, distribution, marketing,
manufacture, use, import, license and/or sale of any of the following, and the Software operating thereon or in connection therewith: (a) Current Business Products; (b) Past Products; (c) Roadmap Products; (d) products that are
included in digital television devices; (e) products that are included in [****] devices; (f) products that are included in [****] devices such as [****] devices; or (g) products [****] devices, [****] devices, and other [****] (other
than [****]). Notwithstanding the foregoing, the “Broadcom Exclusive Field” does not include the design, development, distribution, marketing, manufacture, use, import, license and/or sale of any of the following: (A) all products
made, sold, or marketed by AMD or its Subsidiaries as of the Effective Date, other than the Current Business Products, Past Products or Roadmap Products, (B) future products designed by AMD or its Subsidiaries (other than Current Business
Products, Past Products and Roadmap Products) primarily for use in [****] (and not designed primarily for the products listed in (a) through (g) above), or for use as [****], (C) products for use in [****], or (D) products for
use as [****]. 
 1.4 “Confidential Information” means any and all technical and non-technical information a party
provides to another party hereunder that is marked or otherwise identified at the time of disclosure as confidential or proprietary or is material that should be readily recognized as confidential by the recipient, which information may include
trade secrets, know-how, firmware, designs, schematics, techniques, software code, technical documentation, specifications, Books and Records, plans or any other information relating to any research project, work in process, future development,
scientific, engineering, manufacturing, marketing or business plan or financial, business or personnel matter relating to a party, its present or future products, sales, suppliers, customers, employees, investors or business, whether in written,
oral, graphic or electronic form. Notwithstanding the foregoing, after the Effective Date, all Transferred Technology shall be the Confidential Information of Broadcom, Broadcom shall be deemed to be the disclosing party of such Confidential
Information and AMD shall be deemed to be the recipient of such Confidential Information. All Retained Technology shall be the Confidential Information of AMD. 
  

 2 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 1.5 “Derivative” means a modified version of a Functional Block or of an
integrated circuit comprised of a Current Business Product, Past Product or Roadmap Product. 
 1.6 “Effective
Date” shall be the same date as the Closing Date. 
 1.7 “Excluded Technology” means the
Technology listed on Exhibit C. 
 1.8 “First Effective Filing Date” means the earliest effective
filing date in the particular country for any Patent or any application for any Patent. By way of example, it is understood that the First Effective Filing Date for a United States Patent is the earlier of (a) the actual filing date of the
United States Patent application which issued into such Patent, (b) the priority date under 35 U.S.C. § 119 for such Patent, or (c) the priority date under 35 U.S.C. § 120 for such Patent. 
 1.9 “Functional Block” means an IP core or similar functional block or other component or element within, or Software
in or for, a Current Business Product or Past Product or developed as of the Effective Date for incorporation in a Roadmap Product. 
 1.10
“Game Consoles” means consumer electronic devices that attach to a television and are primarily marketed for the playing of electronic games, such as, or similar to, Microsoft’s Xbox 360, Sony’s PlayStation 3 or
Nintendo’s Wii, and including portable devices that are primarily marketed for the playing of electronic games, such as Nintendo DS. “Game Console” excludes [****]. 
 1.11 “Improvements” means any improvements, enhancements, discoveries, developments, inventions, modifications or
derivative works, whether or not patentable. 
 1.12 “IP Core License Agreement” means the certain IP Core License
Agreement between the parties of even date herewith. 
 1.13 “Licensable” means that, as of the
Effective Date, AMD or any of its Affiliates has the right to grant to Broadcom a license or other rights within the scope of the rights granted to Broadcom under this Agreement, subject to the scope of permissible sublicense rights granted to AMD,
without such grant (a) resulting in any breach or other violation of any obligation of AMD or any of its Affiliates to any Third Party, or (b) resulting in any payment obligations of AMD to any Third Party. 
 1.14 “Mobile Devices” means battery-operated, handheld electronic personal communication devices, such as, or similar to,
cellular telephones, smart phones, PDAs, or pagers, including such devices that are primarily marketed for purposes other than playing electronic games, even if such devices incorporate game-playing functionality, such as, or similar to,
Apple’s iPhone or Research In Motion’s Blackberry. 
 1.15 “PCs” means x86 desktop, notebook or
ultra-mobile personal computers. 
  

 3 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 1.16 “PCTV Devices” means (a) computer cards and products that both
(i) tune, demodulate, process (including encoding, decoding and enhancing audio and video data), record and/or display digital and analog broadcast television signals, and provide related services such as electronic program guides, and
(ii) are included in a PC, or require a PC for operation, and (b) Software operating on such computer cards and integrated circuits to the extent necessary to provide the functionality described in clause (a)(i). 
 1.17 “Retained Intellectual Property Rights” means the Intellectual Property Rights (other than trademarks and Patents) owned or
Licensable by AMD or any of its Affiliates, that are not included in the Transferred Intellectual Property Rights, and that (a) are used in, necessary for or primarily related to the Business or (b) cover any of the Retained Technology.
“Retained Intellectual Property Rights” do not include any of AMD’s Intellectual Property Rights in or to its semiconductor manufacturing Technology. 
 1.18 “Retained Patents” means the claims of Patents owned or Licensable by AMD or any of its Affiliates (other than the Transferred Patents) that (a) without a license, would be infringed
(or, with respect to patent applications, would be infringed if such patent application were to issue as a patent) by the design, development, use, manufacture, import, offer for sale, sale, maintenance, support or other disposal of any Current
Business Product, Past Product or Roadmap Product or any Functional Block, including those Patents listed on Exhibit A, or (b) cover any of the Retained Technology; provided that, such Patents have a First Effective Filing Date on or
before the Effective Date (including, for clarity, all continuations, continuations-in-part, divisionals, substitutions, reissues, reexaminations, and foreign counterparts that claim priority to any such Patents, regardless of when filed or issued).

 1.19 “Retained Technology” means all Technology owned or Licensable by AMD or any of its Affiliates (other than
the Transferred Technology) that is used in, necessary for or primarily related to the Business or the Past Products, any Current Business Product, Roadmap Product or any Functional Block. “Retained Technology” includes the Technology
specifically listed on Exhibit B. For the avoidance of doubt, “Retained Technology” does not include, except as specifically listed on Exhibit B, (w) any of AMD’s proprietary semiconductor manufacturing Technology;
(x) any of the AMD Technology licensed under the IP Core License Agreement; (y) except as licensed under the IP Core License Agreement, any IP core, processor or product that operates as a [****] for use in [****]; or (z) any
processor core or product that (A) is able to execute the object code of any AMD Processor, (B) substantially utilizes the instruction set of any AMD Processor, (C) has a programmer’s model that is substantially compatible with
the programmer’s model of any AMD Processor, or (D) is a chipset (Northbridge/Southbridge) for use with any AMD Processor. 
 1.20
“Third Party” means any person or entity other than AMD or Broadcom or any Affiliate of AMD or Broadcom. 
 1.21 “Transferred Intellectual Property Rights” means the Intellectual Property Rights (other than trademarks and Patents) transferred by AMD or its Subsidiaries to Broadcom or its Subsidiaries pursuant to the APA.

  

 4 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 1.22 “Transferred Patents” means those Patents transferred by AMD or
its Subsidiaries to Broadcom or its Subsidiaries pursuant to the APA. 
 1.23 “Transferred Technology” means the
Technology transferred by AMD or its Subsidiaries to Broadcom or its Subsidiaries in accordance with the APA. 
  

	2.	LICENSES  

 2.1 Licenses to
Broadcom. 
 (a) AMD and its Affiliates hereby grant to Broadcom and its Subsidiaries a perpetual, irrevocable,
non-exclusive, worldwide, fully-paid, royalty-free, non-transferable (except for certain assignments as provided in Section 9.3 (Assignment)) license under the Retained Patents, without right of sublicense, to design, develop, use, make, have
made, import, export, offer to sell, sell, support, maintain and otherwise dispose of: 
 (i) any Current Business Product,
Past Product, Roadmap Product, Functional Block or Derivative, or 
 (ii) any combination of the items described in clause
(i) with each other or with new or additional technology, but only to the extent of the items described in clause (i) and not to any new or additional functionality added to such items (other than Technology which Broadcom is permitted to
use or develop pursuant to the IP Core License Agreement; provided, however, that use or development of such Technology is done in accordance with and remains subject to the restrictions set forth in the IP Core License Agreement) or to
the remainder of any device or product in which such items may be incorporated. 
 For the avoidance of doubt, the restriction on sublicensing set forth
above shall not be interpreted to limit the sublicense rights granted under Section 2.1(b) below; i.e., if a permitted sublicensee’s exercise of its permitted sublicensed rights with respect to the Retained Technology would
necessarily infringe a Retained Patent(s), then Broadcom is permitted to grant a sublicense under such Retained Patents solely to the extent necessary to enable such sublicensee of such Retained Technology to exercise its permitted sublicense rights
in accordance with Section 2.1(b). 
 (b) AMD and its Affiliates hereby grant to Broadcom and its Subsidiaries
(i) under the Retained Intellectual Property Rights, and (ii) to the Retained Technology, a perpetual, irrevocable, worldwide, fully-paid, royalty-free, non-transferable (except for certain assignments as provided in Section 9.3
(Assignment)) license, with right of sublicense (but without further right of sublicense by such sublicensee except to end users of products, solely as necessary for such end users to use such products), to use, reproduce, modify, make derivative
works of, distribute and otherwise exploit the Retained Technology, to design, develop, use, make, have made, import, export, offer to sell, sell, support, maintain and otherwise dispose of products and to provide services. Such license shall be
(A) exclusive within the Broadcom Exclusive Field (even as to AMD and its Affiliates), effective as of the Effective Date and for three (3) years thereafter, and non-exclusive within the Broadcom Exclusive Field effective after the third
(3rd)

  

 5 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 
anniversary of the Effective Date, (B) non-exclusive within the AMD Exclusive Field, effective only after the third (3rd) anniversary of the
Effective Date, and (C) non-exclusive in all fields, other than the Broadcom Exclusive Field and the AMD Exclusive Field, effective as of the Effective Date. 
 (c) The “have made” rights refer only to third party manufacturers or other service providers solely for purposes of having
products designed and/or made on Broadcom’s or its Subsidiaries’ behalf and not to design and/or make products of their own design or products made based upon the designs of Third Parties. 
 (d) Broadcom shall have the exclusive right, but not the obligation, to enforce and protect the Retained Intellectual Property Rights and
Retained Technology against infringement or misappropriation in the Broadcom Exclusive Field arising during the three (3) year period after the Effective Date and may bring and pursue an action to so enforce and protect such rights during or
after such three (3) year period. AMD, or its Affiliate, shall join as a party to any action brought by Broadcom pursuant to such right, at Broadcom’s request and at Broadcom’s expense (including for all reasonable attorneys’
fees and costs of AMD or AMD’s Affiliates), in the event that an adverse party asserts, the court rules or other laws then applicable provide, or Broadcom determines in good faith, that a court lacks jurisdiction based on such AMD’s or
such Affiliate’s absence as a party in such action. If Broadcom lacks standing to bring such an action in any jurisdiction, Broadcom shall have the right to direct AMD or its Affiliate to initiate legal action to enforce the Retained
Intellectual Property Rights and Retained Technology, in accordance with Broadcom’s reasonable instructions and AMD or such Affiliate, as applicable, shall initiate and pursue such action in accordance with Broadcom’s instructions and at
Broadcom’s expense (including for all reasonable attorneys’ fees and costs of AMD or AMD’s Affiliates). Broadcom shall retain or receive all recoveries obtained by either party or their Affiliates from any action or settlement of any
claim or action, brought pursuant to this Section 2.1(d). Broadcom shall indemnify and hold AMD and AMD’s Affiliates harmless from and against any liabilities, losses, damages, costs and expenses, including reasonable attorneys’ fees
and costs, incurred by AMD and its Affiliates, and to promptly reimburse AMD and its Affiliates for any such liabilities, losses, damages, costs and expenses, which are incurred by AMD and its Affiliates, resulting from any actions undertaken by AMD
and its Affiliates requested by Broadcom pursuant to this Section 2.1(d); provided, however, that Broadcom’s indemnification obligation hereunder (i) shall be subject to, and shall not supersede in any way, AMD’s
obligation to indemnify Broadcom pursuant to the APA and Broadcom shall have no obligation to indemnify AMD hereunder for any liability, loss, damage, cost or expense which is subject to AMD’s obligation to indemnify Broadcom pursuant to the
APA; and (ii) is conditioned upon: (A) AMD providing Broadcom with prompt written notice of any such liabilities, losses, damages, costs and expenses, or any Third Party claim which could give rise to such liabilities, losses, damages,
costs and expenses; (B) Broadcom having sole control and authority with respect to the defense and settlement of any such claim; and (C) AMD reasonably cooperating with Broadcom in the defense of any such claim. 
  

 6 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 (e) Broadcom shall not use or hire others to use or analyze any Retained Technology
that is not otherwise publicly available for the purposes of determining if any features, functions or processes provided by the Retained Technology are covered by any patents or patent applications owned by Broadcom and then use that analysis to
assert patent infringement claims against AMD. 
 2.2 License to AMD. 
 (a) Subject to the non-competition terms in Section 5.10(a) of the APA, Broadcom and its Affiliates grant to AMD and AMD’s
Subsidiaries under the Transferred Patents, a perpetual, irrevocable, non-exclusive, worldwide, fully-paid, royalty-free, non-transferable (except for certain assignments as provided in Section 9.3 (Assignment)) license, without right of
sublicense, to use, make, have made, import, support, maintain, offer to sell, sell, and otherwise dispose of products (other than Current Business Products, Past Products and the Roadmap Products). For the avoidance of doubt, the restriction on
sublicensing set forth above shall not be interpreted to limit the sublicense rights granted under Section 2.2(b) below; i.e., if a permitted sublicensee’s exercise of its permitted sublicensed rights with respect to the Transferred
Technology would necessarily infringe a Transferred Patent(s), then AMD is permitted to grant a sublicense under such Transferred Patents solely to the extent necessary to enable such sublicensee of such Transferred Technology to exercise its
permitted sublicense rights in accordance with Section 2.2(b). 
 (b) Subject to the non-competition terms in
Section 5.10(a) of the APA, Broadcom and its Affiliates grant to AMD and AMD’s Subsidiaries (i) under the Transferred Intellectual Property Rights (other than any Transferred Intellectual Property Rights covering the Excluded
Technology), and (ii) to the Transferred Technology (other than the Excluded Technology), a perpetual, irrevocable, non-exclusive, worldwide, fully-paid, royalty-free, non-transferable (except for certain assignments as provided in
Section 9.3 (Assignment)) license, with right of sublicense (in accordance with Section 2.2(e)), to use, reproduce, modify, make derivative works of, and distribute the Transferred Technology (other than the Excluded Technology), to
design, develop, use, make, have made, import, export, offer to sell, sell, support, maintain and otherwise dispose of products and to provide services, in each case other than in the Broadcom Exclusive Field. 
 (c) The “have made” rights refer only to third party manufacturers or other service providers solely for purposes of having
products designed or made on AMD’s or its Subsidiaries’ behalf and not to design or make products of their own design or products made based upon the designs of Third Parties. 
 (d) AMD shall not use or hire others to use or analyze any Transferred Technology that is not otherwise publicly available for the
purposes of determining if any features, functions or processes provided by the Transferred Technology are covered by any patents or patent applications owned by AMD and then use that analysis to assert patent infringement claims against Broadcom.

  

 7 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 (e) AMD and its Subsidiaries may only sublicense any of the rights granted under the
Transferred Intellectual Property Rights and to the Transferred Technology to the following (without any further right of sublicense): 
  

	 	(i)	any independent contractor or other Third Party service provider, solely as necessary to enable such Third Party to provide services to or on behalf of AMD or its Sublicensee, as
applicable; 

  

	 	(ii)	AMD’s and its Subsidiaries’ OEMs and other customers solely as necessary to (A) facilitate collaborative development with AMD or such AMD Subsidiary, as applicable,
of products that incorporate AMD products or components that AMD or its Subsidiaries are commercializing or intending to commercialize, as well as the manufacture, sale and support of any such resulting products; (B) fulfill technology escrow
rights to the extent required to secure business with customers and consistent with escrow requirements applied to the Intellectual Property Rights and Technology of AMD or its Subsidiary in the same products or technology, if applicable;
(C) fulfill second source rights to customers with respect to a single Third Party for each such customer or product (in non-Source Code form and only for products which are created by AMD or such Subsidiary using the Transferred Technology as
permitted under this Agreement), solely to the extent required to secure business with such customer and consistent with the second source requirements applied to the other products of AMD or such Subsidiary, if applicable, sold to such customer; or

  

	 	(iii)	end users of products, solely as necessary for such end users to use such products. 

 2.3 No Other Licenses and Rights. Except as expressly provided in this Section 2, no other license or right is granted to the parties under this Agreement, whether expressly or by implication,
estoppel, statute or otherwise. 
  

	3.	OWNERSHIP 

 3.1 By AMD. As between the
parties, AMD will retain all right, title and interest, including all Intellectual Property Rights, in and to the Retained Technology, in and to any Improvements to the Retained Technology made by or for AMD or its Affiliates, and in and to any
Improvements to the Transferred Technology made by or for AMD or its Subsidiaries in the exercise of the licenses granted to AMD and its Subsidiaries hereunder, subject only to (a) the ownership of Broadcom and its Affiliates in the underlying
Transferred Technology, Transferred Patents and Transferred Intellectual Property Rights, (b) the licenses granted hereunder and (c) the non-competition terms agreed to by AMD pursuant to the APA. Unless otherwise agreed by the parties in
writing, AMD shall have no obligation to disclose or license to Broadcom any Improvements to the Transferred Technology or to the Retained Technology, or to any Intellectual Property Rights in, or to any Improvements to, the Transferred Technology
or the Retained Technology, made by or for AMD or its Affiliates. 
  

 8 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 3.2 By Broadcom. As between the parties, Broadcom will retain all right, title and
interest, including all Intellectual Property Rights, in and to the Transferred Technology, in and to any Improvements to the Transferred Technology made by or for Broadcom or its Affiliates, and in and to any Improvements to any of the Retained
Technology hereunder made by or for Broadcom or its Subsidiaries in the exercise of the licenses granted to Broadcom and its Subsidiaries hereunder, subject only to (a) the ownership of AMD and its Affiliates in the underlying Retained
Technology, Retained Patents and Retained Intellectual Property Rights and (b) the licenses granted hereunder. Unless otherwise agreed by the parties in writing, Broadcom has no obligation to disclose or license to AMD any Improvements to the
Transferred Technology or to the Retained Technology, or to any Intellectual Property Rights in, or to any Improvements to, the Transferred Technology or the Retained Technology, made by or for Broadcom or its Affiliates. 
  

	4.	DISCLAIMER 

 4.1 Disclaimer of
Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THE APA, (a) THE PARTIES ACKNOWLEDGE AND AGREE THAT ALL TECHNOLOGY PROVIDED HEREUNDER, AND ALL INTELLECTUAL PROPERTY RIGHTS LICENSED HEREUNDER, ARE PROVIDED “AS IS,” WITHOUT ANY
WARRANTY OF ANY KIND; AND (b) WITHOUT LIMITING THE FOREGOING, NEITHER PARTY MAKES ANY REPRESENTATION OR WARRANTY REGARDING THE TECHNOLOGY OR INTELLECTUAL PROPERTY RIGHTS LICENSED UNDER THIS AGREEMENT, AND EACH HEREBY EXPRESSLY DISCLAIMS ALL
WARRANTIES OF ANY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY, REGARDING THE INTELLECTUAL PROPERTY AND TECHNOLOGY LICENSED HEREUNDER, INCLUDING ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, ENFORCEABILITY OR
NON-INFRINGEMENT. 
  

	5.	TERM; TERMINATION 

 5.1 Term. The term
of this Agreement is perpetual, with the licenses surviving as long as the applicable Intellectual Property Rights exist. 
 5.2
Termination. This Agreement may only be terminated by express mutual written agreement of the parties in the form of an amendment to this Agreement. 
  

 9 
 [****] =
Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

	6.	ADDITIONAL OBLIGATIONS 

 6.1 Additional
Obligations with Regard to Patents. 
 (a) Broadcom agrees, on behalf of itself and its Affiliates, to make reasonably
available to AMD and its Affiliates, or their counsel, on reasonable advance written notice during normal business hours, inventors and other persons previously employed by AMD or its Affiliates, who are Continuing Employees and are employed by
Broadcom or is Affiliates at the time of the request, for interviews or testimony to assist in good faith in further prosecution, maintenance, or litigation of all Retained Patents and Retained Intellectual Property Rights, including the signing of
documents related thereto. Any reasonable attorneys’ fees and costs associated with such assistance shall be borne by AMD, expressly excluding the value of the time of such personnel for maintenance or prosecution, but, with respect to
litigation, including the value of the time of such personnel, as well as reasonable attorneys’ fees associated with such personnel’s participation in litigation on behalf of AMD, as agreed upon in advance in writing by AMD and Broadcom in
good faith. 
 (b) AMD agrees, on behalf of itself and its Affiliates, to make reasonably available to Broadcom and its
Affiliates, or their counsel, on reasonable advance written notice during normal business hours, inventors and other persons employed by AMD or its Affiliates at the time of the request, for interviews or testimony to assist in good faith in further
prosecution, maintenance, or litigation of all Transferred Patents and Transferred Intellectual Property Rights, including the signing of documents related thereto. Any reasonable attorneys’ fees and costs associated with such assistance shall
be borne by Broadcom, expressly excluding the value of the time of such personnel for maintenance or prosecution, but, with respect to litigation, including the value of the time of such personnel, as well as reasonable attorneys’ fees
associated with such personnel’s participation in litigation on behalf of Broadcom, as agreed upon in advance in writing by AMD and Broadcom in good faith. 
 6.2 No Other Obligation. Except as expressly set forth in Section 2.1(d), neither party shall have any obligation hereunder to institute or maintain any action or suit against third parties for
infringement or misappropriation of any Intellectual Property Right in or to any Technology licensed to the other party hereunder, or to defend any action or suit brought by a Third Party that challenges or concerns the validity of any of such
rights or that claims that any Technology licensed to the other party hereunder infringes or constitutes a misappropriation of any Intellectual Property Right of any Third Party. 
 6.3 No Obligation to Obtain or Maintain Rights in Technology. Except as otherwise set forth herein, in the APA or any agreement or document
referenced in the APA, no party shall be obligated under this Agreement to provide the other parties with any technical assistance or to furnish the other parties with, or obtain, any documents, materials or other information or Technology.

  

 10 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 6.4 No Obligation to Obtain Or Maintain Patents. No party is obligated to (i) file
any patent application, or to secure any patent or patent rights or (ii) to maintain any patent in force. 
  

	7.	CONFIDENTIALITY 

 7.1 Restrictions on Use of
Confidential Information. All Confidential Information shall not be distributed, disclosed, or disseminated in any way or form by the receiving party to anyone except its own, and its Affiliates’ and permitted sublicensees’,
employees, contractors, customers and business partners who have a reasonable need to know such Confidential Information and who have been advised of the confidential nature and required to observe the terms and conditions hereof or of terms
substantially similar to these confidentiality provisions; nor shall Confidential Information be used by the receiving party for its own purpose, except for the purposes of exercising its rights or fulfilling its obligations under this Agreement or
any permitted sublicense. The recipient shall treat all of the disclosing party’s Confidential Information with the same degree of care as the recipient accords to recipient’s own Confidential Information, but not less than reasonable
care. The recipient shall immediately give notice to the disclosing party of any unauthorized use or disclosure of disclosing party’s Confidential Information. The recipient shall assist the disclosing party in remedying any such unauthorized
use or disclosure of the disclosing party’s Confidential Information. AMD agrees that during the three (3) year period in which Broadcom is granted an exclusive license under Section 2.1(b) above, AMD and its Affiliates will not
publicly disclose the Retained Technology in a manner that would result in a loss of trade secret status for the material trade secret aspects of the [****] as of the Effective Date for Broadcom’s use of the [****] in accordance with the
license rights Broadcom receives to such Retained Technology under Section 2.1(b). Notwithstanding the foregoing, AMD or its Affiliates may publish a non-confidential programming guide that details registers and microcode APIs applicable to the
[****] so that developers may develop drivers and other applicable software to configure their devices and access those of AMD’s or its Affiliates’ products, the design, development, use, manufacture, having manufactured, importation,
export, offering to sell, sale, support, maintenance or other disposal of which do not violate any exclusive license granted to Broadcom hereunder. 
 7.2 Exceptions. The obligation not to disclose information under Section 7.1 hereof shall not apply to information that, as of the Effective Date or thereafter, (a) was in the public domain or otherwise publicly
known at or subsequent to the time such Confidential Information was communicated to recipient by the disclosing party through no fault of the recipient; (b) other than with respect to Transferred Technology, was rightfully in the
recipient’s possession free of any obligation of confidence at or subsequent to the time such Confidential Information was communicated to the recipient by the disclosing party; (c) was developed by employees or agents of the recipient
independently of and without reference to any of the disclosing party’s Confidential Information; or (d) was communicated by the disclosing party to a Third Party free of any obligation of confidence. 
  

 11 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 7.3 Confidentiality of Agreement and Permitted Disclosures. Except as expressly
provided herein, each party agrees that the terms and conditions of this Agreement shall be treated as confidential and that neither party will disclose the terms or conditions of this Agreement to any third party without the prior written consent
of the other party, provided, however, that each party may disclose the terms and conditions of this Agreement and the other party’s Confidential Information to the extent necessary: (a) as required by any court or other governmental body;
(b) as otherwise required by law (including the rules and regulations of any stock exchange) or expressly permitted under this Agreement; (c) in confidence to such party’s legal counsel, accountants, and other professional advisors;
(d) in confidence, to banks, investors and other financing sources and their advisors; (e) in connection with the enforcement of this Agreement or exercise of rights under this Agreement; or (f) in confidence, in connection with an
actual or prospective merger or acquisition or similar transaction. With respect to disclosure required by a court, governmental order or otherwise required by law, the party required to so disclose shall (i) to the extent not prohibited,
provide prior notification of such impending disclosure to the other party, (ii) use all reasonable efforts to preserve the confidentiality of the terms of this Agreement in complying with such required disclosure, including obtaining a
protective order to the extent reasonably possible, and (iii) not be relieved of its obligation of confidentiality and non-use of such disclosed information for any other purpose. Further, all other individuals and/or entities receiving
Confidential Information pursuant to subsections (c) through (f) must have signed a written non-disclosure agreement protecting the Confidential Information in accordance with terms in this Agreement, or with respect to attorneys and other
professional advisors, be bound by ethical obligations to protect the Confidential Information. 
 7.4 Duration. The
obligations of the parties set forth in this Section 7 with respect to the protection of Confidential Information shall remain in effect for five (5) years after (a) the Effective Date, with respect to Confidential Information of one
party that is known to or in the possession of the other party as of the Effective Date, or (b) the date of disclosure, with respect to Confidential Information that is disclosed by the one party to the other party after the Effective Date,
provided, however, that the obligations of the parties set forth in this Section 7 with respect to the protection of Confidential Information that is Source Code or that otherwise constitutes or is treated as of the Effective Date by the
disclosing party as a trade secret shall remain in effect perpetually, subject only to the exceptions in Section 7.2. 
  

	8.	LIMITATION OF LIABILITY 

 TO THE MAXIMUM EXTENT PERMITTED BY
APPLICABLE LAW, AND EXCEPT FOR BREACHES OF CONFIDENTIALITY OBLIGATIONS, OR BREACHES OF LICENSE OR FIELD RESTRICTIONS, IN NO EVENT SHALL A PARTY BE LIABLE UNDER THIS AGREEMENT TO THE OTHER PARTY OR TO ANY PARTY CLAIMING THROUGH OR UNDER ANOTHER
PARTY, FOR ANY LOST PROFITS, OR FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES, WHETHER IN AN ACTION IN CONTRACT, TORT (INCLUDING STRICT LIABILITY), BASED ON A WARRANTY, OR OTHERWISE, ARISING OUT OF OR IN CONNECTION WITH THIS
AGREEMENT, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
  

 12 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

	9.	MISCELLANEOUS PROVISIONS 

 9.1 Governing Law;
Venue. This Agreement and any disputes hereunder shall be governed by and construed in accordance with the domestic laws of the State of California, without giving effect to any choice of law or conflict of law provision or rule (whether of
the State of California or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of California. Any dispute, claim or controversy arising out of this Agreement shall be submitted to the
exclusive jurisdiction and venue in the federal and state courts located in and serving Santa Clara County, California. Notwithstanding the foregoing, in the event that any dispute, claim or controversy arising out of this Agreement also involves a
dispute, claim or controversy arising out of the APA, the governing law and dispute resolution provisions of the APA shall govern all such disputes, claims and controversies. 
 9.2 Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered
in person, by telecopy with answer back, by express or overnight mail delivered by a nationally recognized air courier (delivery charges prepaid), by registered or certified mail (postage prepaid, return receipt requested) or by e-mail with receipt
confirmed by return e-mail to the respective parties as follows: 
 if to AMD: 
 Advanced Micro Devices, Inc. 
 7171 Southwest
Parkway 
 Austin, Texas 78735 
 Attention: General Counsel 
 Fax: (512) 602-4999 
 if to Broadcom: 
 Broadcom Corporation 
 5300 California Ave. 
 Irvine, California
92617 
 Attention: General Counsel 
 Fax: (949) 926-9244 
 or to such other address as the party to whom notice is given may have previously furnished to the other in writing in
the manner set forth above. Any notice or communication delivered in person shall be deemed effective on delivery. Any notice or communication sent by e-mail, telecopy or by air courier shall be deemed effective on the first Business Day following
the day on which such notice or communication was sent. Any notice or communication sent by registered or certified mail shall be deemed effective on the third Business Day following the day on which such notice or communication was mailed.

  

 13 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 9.3 Assignment. In addition to the sublicense rights enumerated in Section 2.1 and
Section 2.2, in the event of a sale of any portion of the business of either party that utilizes the license granted hereby, either party may grant sublicenses to the purchaser of such portion of the business (including as to AMD, AMD’s
handheld business unit) to be used by such purchaser solely in connection with the business sold to the purchaser and not for any other business. No party may, directly or indirectly, in whole or in part, whether voluntarily or involuntarily or by
operation of law or otherwise, assign or transfer this Agreement and the rights granted to it hereunder without the other party’s prior written consent, which consent may be granted or refused at the other party’s sole discretion.
Notwithstanding the foregoing, either party may assign this Agreement and the rights granted to it hereunder, subject to its obligations, to a successor in interest, without the consent of the other party, upon any merger, acquisition,
reorganization, change of control, or sale of all or substantially all of the assets or business of such party or the sale of all or substantially all of the assets or the business related to the Intellectual Property Rights and Technology licensed
to such party under this Agreement, to be used by the successor solely in connection with the business sold to the successor and not for any other business. Any assignment in violation of this Section shall be null and void from the beginning, and
shall be deemed a material breach of this Agreement. AMD shall not assign, transfer or otherwise divest any right, title or interest in or to Retained Technology, Retained Intellectual Property Rights or Retained Patents unless (a) such
assignment, transfer or other divestiture is subject to all of the rights granted to Broadcom under this Agreement, and (b) the Person(s) to whom such right, title or interest is transferred is informed in writing, on or before the
effectiveness of such assignment, transfer or divestiture, of the rights granted to Broadcom under this Agreement. 
 9.4 Relationship
Between Parties. Broadcom and AMD shall at all times and for all purposes be deemed to be independent contractors and neither party, its Affiliates, nor either party’s or its Affiliates’ employees, representatives, subcontractors
or agents, shall have the right or power to bind the other party. This Agreement shall not itself create or be deemed to create a joint venture, partnership or similar association between Broadcom and AMD or either party’s or its
Affiliates’ employees, representatives, subcontractors or agents. 
 9.5 Third Party Beneficiaries. The terms and
provisions of this Agreement are intended solely for the benefit of Broadcom and its Subsidiaries, on the one hand, and AMD and its Subsidiaries, on the other hand. It is not the intention of the parties to confer third-party beneficiary rights upon
any other person or entity, and this Agreement does not (shall not be construed to) confer any right or cause of action in, upon or on behalf of any other person or entity, and no person or entity (including any of employee or former employee of any
of the parties) other than Broadcom or its Subsidiaries and AMD or its Subsidiaries shall be entitled to rely on any provision of this Agreement in any action proceeding, hearing or other forum. 
 9.6 Severability. In the event that any clause, sub-clause or other provision contained in this Agreement shall be determined by any
competent authority to be invalid, unlawful or unenforceable to any extent, such clause, sub-clause or other provision shall to that extent be severed from the remaining clauses and provisions, or the remaining part of the clause in question, which
shall continue to be valid and enforceable to the fullest extent permitted by law. 
  

 14 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 9.7 No Waiver; Remedies Cumulative. Failure or neglect by a party to enforce at any
time any of the provisions hereof shall not be construed nor shall be deemed to be a waiver of such party’s rights hereunder nor in any way affect the validity of the whole or any part of this Agreement nor prejudice such party’s rights to
take subsequent action. All rights and remedies conferred under this Agreement or by any other instrument or law shall be cumulative and may be exercised singularly or concurrently. 
 9.8 Amendment. Any term of this Agreement may be amended, modified, rescinded, canceled or waived, in whole or in part, only by a written
instrument signed by each of the parties’ authorized representatives or their respective permitted successors and assigns. Any amendment or waiver effected in accordance with this Section shall be binding upon the parties and their respective
successors and assigns. 
 9.9 Counterparts. This Agreement may be executed in two or more counterparts, all of which, taken
together, shall be considered to be one and the same instrument. 
 9.10 Headings; Construction. The headings to the clauses,
sub-clauses and parts of this Agreement are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. The terms “this Agreement,” “hereof,”
“hereunder” and any similar expressions refer to this Agreement and not to any particular Section or other portion hereof. The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the
drafting party will not be applied in the construction or interpretation of this Agreement. As used in this Agreement, the words “include” and “including,” and variations thereof, will be deemed to be followed by the words
“without limitation” and “discretion” means sole discretion. 
 9.11 Entire Agreement. With the exception
of the APA and the Ancillary Agreements, this Agreement (including its Exhibits, each of which are incorporated herein by this reference) supersedes any arrangements, understandings, promises or agreements made or existing between the parties hereto
prior to or simultaneously with this Agreement with respect to the subject matter hereof and thereof and constitutes the entire understanding between the parties hereto with respect to the subject matter hereof, except for the Project Addendum and
Exclusivity Agreement, which shall continue as set forth in Section 5.2 of the APA. 
 9.12 Statement of Intent With Respect to
Bankruptcy. Each party’s rights under this Agreement are perpetual, irrevocable, and nonexecutory, notwithstanding any other provision of this Agreement or any other contract, and to the maximum extent permitted by applicable
law. In the event of the commencement of a bankruptcy proceeding by or against a party, the license grant to the other party in Article 2 shall continue in full force and effect. Under no circumstances shall the other party’s exercise of the
rights granted to it in Article 2 ever be construed as an infringement of the licensor party’s rights in the Retained Patents, the Retained Intellectual Property Rights, the Retained Technology, the Transferred Patents, the Transferred 

  

 15 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 
Intellectual Property Rights or the Transferred Technology, as applicable. In the event that a bankruptcy court or other court of competent jurisdiction ever
determines by final judgment that this Agreement is executory, despite every intention and effort by the parties to negotiate and document nonexecutory rights for the other party, and without implying any acceptance of the rejected concept that it
is legally impossible to create such a nonexecutory license for Intellectual Property Rights or Technology, all rights and licenses granted under or pursuant to this Agreement are, and shall otherwise be deemed to be, for purposes of
Section 365(n) of the U.S. Bankruptcy Code, licenses of rights to “intellectual property” as defined under Section 101 of the U.S. Bankruptcy Code and the APA is an agreement “supplemental to” this license. Furthermore,
in such an event, the parties agree that each party, as a licensee of rights under this Agreement, shall retain and may fully exercise all of its rights and elections under the U.S. Bankruptcy Code and other applicable law, including any right by
such party to specific performance of this Agreement, since each party acknowledges and agrees that the Retained Patents, Retained Intellectual Property Rights, Retained Technology, Transferred Patents, Transferred Intellectual Property Rights and
Transferred Technology are unique and that rejection of the license will cause the other party irreparable harm for which its legal remedies are inadequate; provided, however, nothing herein shall be deemed to constitute a present exercise of such
rights and elections. 
 9.13 Export. In recognition of U.S. and non-U.S. export control laws and regulations, each
party agrees that it will not export, or transfer for the purpose of re-export, any product, technical data received hereunder or any product produced by use of such technical data, including processes and services, (each, an “Exported
Product”), in violation of any U.S. or non-US regulation, treaty, executive order, law, statute, amendment or supplement thereto. Further, neither party will export an Exported Product to any prohibited or embargoed country or to any
denied, blocked, or designated person or entity as mentioned in any such U.S. or non-US regulation, treaty, executive order, law, statute, amendment or supplement thereto. 
 [Balance of page intentionally left blank.] 
  

 16 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 IN WITNESS WHEREOF, the parties have signed this Intellectual Property Cross-License Agreement effective as of the
Effective Date. 
  

			
	ADVANCED MICRO DEVICES, INC.
		
	By:	 	/s/ Harry A. Wolin
		 	Name: Harry A. Wolin
		 	Title: Sr. Vice President, General Counsel & Secretary

 SIGNATURE PAGE TO IP CORE LICENSE 
  

 [****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed
separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

			
	BROADCOM CORPORATION
		
	By:	 	/s/ Scott A. McGregor
		 	Name: Scott A. McGregor
		 	Title: President and Chief Executive Officer

 SIGNATURE PAGE TO IP CORE LICENSE 
  

 [****] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed
separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 EXHIBIT A 
 LIST OF MATERIAL RETAINED PATENTS 
  

											
	Title	  	Country	  	Application
No.	  	Filing
Date	  	Publication /
Patent No.	  	Publication /
Issue Date
	[****]	  	[****]	  	[****]	  	[****]	  	[****]	  	[****]

  

 A-1 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 EXHIBIT B 
 LIST OF MATERIAL RETAINED TECHNOLOGY 
 [****] 
  

 B-1 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions. 

 EXECUTION VERSION 
 AMD AND BROADCOM CONFIDENTIAL 
  

 EXHIBIT C 
 EXCLUDED TECHNOLOGY 
 [****] 
  

 C-1 
 [****]
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]